Millennium Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-45,861
| Closed | -$144K | – | 5875 |
|
|
2020
Q3 | $144K | Sell |
45,861
-113,158
| -71% | -$361K | ﹤0.01% | 4155 |
|
|
2020
Q2 | $463K | Buy |
159,019
+145,120
| +1,044% | +$459K | ﹤0.01% | 3449 |
|
|
2020
Q1 | $39K | Sell |
13,899
-676,972
| -98% | -$2.18M | ﹤0.01% | 3688 |
|
|
2019
Q4 | $2.24M | Buy |
690,871
+442,251
| +178% | +$1.28M | ﹤0.01% | 2549 |
|
|
2019
Q3 | $537K | Sell |
248,620
-175,432
| -41% | -$469K | ﹤0.01% | 3207 |
|
|
2019
Q2 | $1.33M | Buy |
424,052
+355,364
| +517% | +$1.15M | ﹤0.01% | 2633 |
|
|
2019
Q1 | $256K | Sell |
68,688
-225,154
| -77% | -$760K | ﹤0.01% | 3636 |
|
|
2018
Q4 | $852K | Buy |
293,842
+92,697
| +46% | +$255K | ﹤0.01% | 2668 |
|
|
2018
Q3 | $529K | Buy |
201,145
+182,768
| +995% | +$449K | ﹤0.01% | 3224 |
|
|
2018
Q2 | $43K | Sell |
18,377
-238,164
| -93% | -$665K | ﹤0.01% | 3712 |
|
|
2018
Q1 | $754K | Sell |
256,541
-1,321,065
| -84% | -$3.61M | ﹤0.01% | 2839 |
|
|
2017
Q4 | $4.32M | Sell |
1,577,606
-1,942,992
| -55% | -$5.97M | 0.01% | 1810 |
|
|
2017
Q3 | $11.9M | Buy |
3,520,598
+3,074,010
| +688% | +$8.55M | 0.02% | 1135 |
|
|
2017
Q2 | $1.1M | Buy |
446,588
+331,527
| +288% | +$763K | ﹤0.01% | 2400 |
|
|
2017
Q1 | $261K | Sell |
115,061
-524,109
| -82% | -$1.16M | ﹤0.01% | 3106 |
|
|
2016
Q4 | $1.36M | Buy |
639,170
+378,581
| +145% | +$1.06M | ﹤0.01% | 2082 |
|
|
2016
Q3 | $873K | Sell |
260,589
-333,189
| -56% | -$1.06M | ﹤0.01% | 2338 |
|
|
2016
Q2 | $1.86M | Sell |
593,778
-1,100,609
| -65% | -$3.67M | ﹤0.01% | 1824 |
|
|
2016
Q1 | $5.64M | Sell |
1,694,387
-741,385
| -30% | -$2.31M | 0.01% | 1177 |
|
|
2015
Q4 | $8.62M | Buy |
2,435,772
+1,883,196
| +341% | +$7.88M | 0.02% | 1008 |
|
|
2015
Q3 | $2.78M | Sell |
552,576
-344,039
| -38% | -$1.97M | 0.01% | 1699 |
|
|
2015
Q2 | $5.76M | Sell |
896,615
-377,831
| -30% | -$2.53M | 0.01% | 1309 |
|
|
2015
Q1 | $8.97M | Buy |
1,274,446
+1,001,340
| +367% | +$7.25M | 0.02% | 1077 |
|
|
2014
Q4 | $2.11M | Buy |
273,106
+109,133
| +67% | +$864K | ﹤0.01% | 1937 |
|
|
2014
Q3 | $1.22M | Buy |
+163,973
| New | +$1.52M | ﹤0.01% | 2175 |
|
|
2014
Q2 | – | Sell |
-51,600
| Closed | -$429K | – | 4295 |
|
|
2014
Q1 | $429K | Sell |
51,600
-29,900
| -37% | -$256K | ﹤0.01% | 2714 |
|
|
2013
Q4 | $688K | Buy |
81,500
+52,959
| +186% | +$446K | ﹤0.01% | 2517 |
|
|
2013
Q3 | $227K | Sell |
28,541
-63,684
| -69% | -$512K | ﹤0.01% | 3032 |
|
|
2013
Q2 | $712K | Buy |
+92,225
| New | +$719K | ﹤0.01% | 2145 |
|
Other funds holding PDLI
JC
Millennium Management's PDLI Position: Q4 2020 in Review
Millennium Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 45,861 shares — an estimated $144K sold.
Millennium Management first reported a position in PDLI in Q2 2013 and held it in 29 quarters. The position peaked at $11.9M in Q3 2017. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.
- Millennium Management reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
- Millennium Management sold 45,861 PDL BioPharma, Inc. shares in Q4 2020, an estimated $144K.
- Millennium Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 29 quarters.
- Millennium Management's PDL BioPharma, Inc. position peaked at $11.9M in Q3 2017.
- 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.